LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer

Triple negative breast cancer (TNBC) is an aggressive type of breast cancer with high heterogeneity. To date, there is no efficient therapy for TNBC patients and the prognosis is poor. It is urgent to find new biomarkers for the diagnosis of TNBC or efficient therapy targets. As an area of focus in...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Lv, Mingming, Xu, Pengfei, Wu, Ying, Huang, Lei, Li, Wenqu, Lv, Shanshan, Wu, Xiaowei, Zeng, Xin, Shen, Rong, Jia, Xuemei, Yin, Yongmei, Gu, Yun, Yuan, Hongyan, Xie, Hui, Fu, Ziyi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2016
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914340/
https://ncbi.nlm.nih.gov/pubmed/26910840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7509
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items